MITOSENSE, INC.
Plymouth, MA · Founded 2019 · CIK 0001804492 · Biotech · Private
Mitochondrial replenishment therapeutics targeting neurodegenerative diseases
mitosenseinc.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.2M
- 3 Form D · Jan 2024
- 33 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $60,000 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $1,930,661 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1491 | CERACUITY, INC. | — | $3K |
| 1492 | ProtaBody, Inc. | — | $800 |
| 1493 | SynPhaGen, LLC | — | — |
| 1494 | MITOSENSE, INC. | — | $2.2M |
| 1495 | GFREE BIO, LLC | — | — |
| 1496 | BEXION PHARMACEUTICALS, INC. | — | — |
| 1497 | Viewpoint Therapeutics, Inc. | — | $25M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Catherine BaucomDirector · Executive Officer
- CATHERINE BAUCOMExecutive Officer
- ROBERT ELLIOTTDirector · Executive Officer
- Andrew FinnDirector · Executive Officer
- ANDREW FINNDirector · Executive Officer
- Van Hipp Jr.Director · Executive Officer
- Van Hipp, Jr.Director · Executive Officer
- VAN HIPP, JR.Director · Executive Officer
- Xianpeng JiangDirector · Executive Officer
- XIANPENG JIANGDirector · Executive Officer
- Tidal McCoyDirector · Executive Officer
- TIDAL MCCOYDirector · Executive Officer
- Brent SegalDirector · Executive Officer
- BRENT SEGALDirector · Executive Officer
- Richard WaldoDirector
- Carla YorkExecutive Officer
- CARLA YORKExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.